wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55230293-64A043B8-62E4-4C66-A4D8-596EA292624A
Q55230293-64A043B8-62E4-4C66-A4D8-596EA292624A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55230293-64A043B8-62E4-4C66-A4D8-596EA292624A
Osimertinib: A Novel Therapeutic Option for Overcoming T790M Mutations in Non-Small Cell Lung Cancer.
P2860
Q55230293-64A043B8-62E4-4C66-A4D8-596EA292624A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55230293-64A043B8-62E4-4C66-A4D8-596EA292624A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c9dadd4cd0b3c70ebcbf2736b417c87cf87ec03d
P2860
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.